Cargando…
Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches
Influenza virus-like particle vaccines are one of the most promising ways to respond to the threat of future influenza pandemics. VLPs are composed of viral antigens but lack nucleic acids making them non-infectious which limit the risk of recombination with wild-type strains. By taking advantage of...
Autores principales: | Thompson, Christine M, Petiot, Emma, Lennaertz, Alexandre, Henry, Olivier, Kamen, Amine A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655918/ https://www.ncbi.nlm.nih.gov/pubmed/23642219 http://dx.doi.org/10.1186/1743-422X-10-141 |
Ejemplares similares
-
Developing a production process for influenza VLPs: a comparison between HEK 293SF and Sf9 production platforms
por: Thompson, Christine M, et al.
Publicado: (2013) -
Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems
por: Thompson, Christine M, et al.
Publicado: (2015) -
Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines
por: Milián, Ernest, et al.
Publicado: (2015) -
Cellular signaling pathways modulated by influenza infection in HEK293 cells
por: Manceur, Aziza P, et al.
Publicado: (2015) -
Metabolic and Kinetic analyses of influenza production in perfusion HEK293 cell culture
por: Petiot, Emma, et al.
Publicado: (2011)